ADIPOQ and myocarditis: In this study we evaluated the role of sVCAM-1 as a biomarker in myocarditis in EAM, a model of myocarditis and DCMi.[16] Recent findings indicate that DCM arises from chronic ongoing inflammation due to viral persistence or chronic autoimmune processes.[17] Lately, high adiponectin levels have been shown to predict favourable outcome in patients with myocarditis.[16] Nevertheless, to date, no biomarker reliably reveals the diagnosis and/or depicts the severity of myocarditis at various stages of the disease.